Scientists at the University of Colorado Anschutz Medical Campus have made a `paradigm shifting’ discovery on the mechanisms required for learning and memory that could lead to new therapies for Alzheimer’s disease and potentially Down syndrome.
The raise this week follows what he calls a “pivotal” development that will likely land one of its cancer treatments in clinical trials early next year. Click here to view original post
The COVID-19 pandemic illuminated a vast landscape of misinformation about many topics, science and health chief among them. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
BOULDER, Colo., Sept. 10, 2024 (GLOBE NEWSWIRE) — Foresight Diagnostics (Foresight), a leader in ultra-sensitive minimal residual disease (MRD) detection, today announced an upcoming presentation featuring its Foresight CLARITY™ MRD platform at the ESMO Congress […]
Copyright © 2026 Biotech Networks
